Form 4 for HCAT Health Catalyst, Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2021-12-02 · accession 0001562180-21-007530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $12.72 | +53.2K | 278.1K | +24% | +$677.1K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Burton Daniel D. | CEO, Dir | S - Sale+OE | $40.41 | -58.2K | 241.9K | -19% | -$2.35M |
| D | 2021-12-07 | 2021-12-02 | HCAT | Burton Daniel D. | CEO, Dir | F - Tax | $41.95 | -4,410 | 241.9K | -2% | -$185.0K |
| DM | 2021-12-07 | 2021-12-03+ | HCAT | Burton Daniel D. | CEO, Dir | M - OptEx | $0.00 | -53.2K | 94.8K | -36% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-03 | M | A | 21,781 | $10.80 | 263,652 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-03 | S | D | 10,127 | $41.47 | 242,071 | D | — | — | (F5) Represents the weighted average sale price of the shares sold ranging from $41.09 to $41.79 per share, inclusive. |
| 3 | Common | Common Stock | 2021-12-06 | M | A | 5,881 | $15.84 | 258,878 | D | — | — | |
| 4 | Common | Common Stock | 2021-12-06 | M | A | 11,126 | $10.80 | 252,997 | D | — | — | |
| 5 | Common | Common Stock | 2021-12-03 | S | D | 25,885 | $40.28 | 252,198 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.92 per share, inclusive. |
| 6 | Common | Common Stock | 2021-12-03 | M | A | 14,431 | $15.84 | 278,083 | D | — | — | |
| 7 | Common | Common Stock | 2021-12-06 | S | D | 21,972 | $40.06 | 236,906 | D | — | — | (F7) Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (7). |
| 8 | Common | Common Stock | 2021-12-02 | F | D | 4,410 | $41.95 | 241,871 | D | — | — | (F2) Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade. |
| 9 | Common | Common Stock | 2021-12-03 | S | D | 200 | $42.13 | 241,871 | D | — | — | (F6) Represents the weighted average sale price of the shares sold ranging from $42.10 to $42.36 per share, inclusive. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-12-06 | M | D | 11,126 | $0.00 | 173,273 | D | $10.80 · — to 2028-09-27 | 11,126 Common Stock | (F9) 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |
| 11 | Derivative | Stock Option (Right to Buy) | 2021-12-06 | M | D | 5,881 | $0.00 | 88,934 | D | $15.84 · — to 2029-02-05 | 5,881 Common Stock | (F8) 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |
| 12 | Derivative | Stock Option (Right to Buy) | 2021-12-03 | M | D | 21,781 | $0.00 | 184,399 | D | $10.80 · — to 2028-09-27 | 21,781 Common Stock | (F9) 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022. |
| 13 | Derivative | Stock Option (Right to Buy) | 2021-12-03 | M | D | 14,431 | $0.00 | 94,815 | D | $15.84 · — to 2029-02-05 | 14,431 Common Stock | (F8) 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. |